Kazakhstan Pharmaceuticals & Healthcare Q3 2019
We maintain our bullish growth outlook for Kazakhstan’s pharmaceutical market. The government has placedconsiderable focus on improving patient access to healthcare services and medicines, with the rapid pace of development ofregulatory policies. Although the implementation of the unified medicine price policy may result in lower prices for some drugs inthe short term, we believe that the increased patient access will bode well for drugmakers overall. Over the longer term, growth willdecelerate as the need for government cost contentment will increase.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook